Estrogen receptor status in inflammatory breast carcinoma

Harold Harvey, Allan Lipton, Bellarmine V. Lawrence, Deborah S. White, Samuel A. Wells, George Blumenschein, David Lee

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Sixteen women with a clinical diagnosis of inflammatory breast carcinoma had estrogen receptor analysis performed. Eleven of 16 were premenopausal. Median age of all patients was 46 years. All patients had estrogen receptor (ER) assay by either dextran charcoal method or by sucrose gradient method. Five patients were ER+ (⩾ fmol/mg cytosol protein) and 11 were ER‐, with almost no binding at all. Response to therapy for metastatic disease using either hormones or chemotherapy was disappointing.

Original languageEnglish (US)
Pages (from-to)42-44
Number of pages3
JournalJournal of Surgical Oncology
Volume21
Issue number1
DOIs
StatePublished - Jan 1 1982

Fingerprint

Inflammatory Breast Neoplasms
Estrogen Receptors
Charcoal
Dextrans
Cytosol
Sucrose
Hormones
Drug Therapy
Proteins

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Harvey, H., Lipton, A., Lawrence, B. V., White, D. S., Wells, S. A., Blumenschein, G., & Lee, D. (1982). Estrogen receptor status in inflammatory breast carcinoma. Journal of Surgical Oncology, 21(1), 42-44. https://doi.org/10.1002/jso.2930210111
Harvey, Harold ; Lipton, Allan ; Lawrence, Bellarmine V. ; White, Deborah S. ; Wells, Samuel A. ; Blumenschein, George ; Lee, David. / Estrogen receptor status in inflammatory breast carcinoma. In: Journal of Surgical Oncology. 1982 ; Vol. 21, No. 1. pp. 42-44.
@article{6b3a8c7f208e46af8c36df3998cbfb07,
title = "Estrogen receptor status in inflammatory breast carcinoma",
abstract = "Sixteen women with a clinical diagnosis of inflammatory breast carcinoma had estrogen receptor analysis performed. Eleven of 16 were premenopausal. Median age of all patients was 46 years. All patients had estrogen receptor (ER) assay by either dextran charcoal method or by sucrose gradient method. Five patients were ER+ (⩾ fmol/mg cytosol protein) and 11 were ER‐, with almost no binding at all. Response to therapy for metastatic disease using either hormones or chemotherapy was disappointing.",
author = "Harold Harvey and Allan Lipton and Lawrence, {Bellarmine V.} and White, {Deborah S.} and Wells, {Samuel A.} and George Blumenschein and David Lee",
year = "1982",
month = "1",
day = "1",
doi = "10.1002/jso.2930210111",
language = "English (US)",
volume = "21",
pages = "42--44",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Harvey, H, Lipton, A, Lawrence, BV, White, DS, Wells, SA, Blumenschein, G & Lee, D 1982, 'Estrogen receptor status in inflammatory breast carcinoma', Journal of Surgical Oncology, vol. 21, no. 1, pp. 42-44. https://doi.org/10.1002/jso.2930210111

Estrogen receptor status in inflammatory breast carcinoma. / Harvey, Harold; Lipton, Allan; Lawrence, Bellarmine V.; White, Deborah S.; Wells, Samuel A.; Blumenschein, George; Lee, David.

In: Journal of Surgical Oncology, Vol. 21, No. 1, 01.01.1982, p. 42-44.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estrogen receptor status in inflammatory breast carcinoma

AU - Harvey, Harold

AU - Lipton, Allan

AU - Lawrence, Bellarmine V.

AU - White, Deborah S.

AU - Wells, Samuel A.

AU - Blumenschein, George

AU - Lee, David

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Sixteen women with a clinical diagnosis of inflammatory breast carcinoma had estrogen receptor analysis performed. Eleven of 16 were premenopausal. Median age of all patients was 46 years. All patients had estrogen receptor (ER) assay by either dextran charcoal method or by sucrose gradient method. Five patients were ER+ (⩾ fmol/mg cytosol protein) and 11 were ER‐, with almost no binding at all. Response to therapy for metastatic disease using either hormones or chemotherapy was disappointing.

AB - Sixteen women with a clinical diagnosis of inflammatory breast carcinoma had estrogen receptor analysis performed. Eleven of 16 were premenopausal. Median age of all patients was 46 years. All patients had estrogen receptor (ER) assay by either dextran charcoal method or by sucrose gradient method. Five patients were ER+ (⩾ fmol/mg cytosol protein) and 11 were ER‐, with almost no binding at all. Response to therapy for metastatic disease using either hormones or chemotherapy was disappointing.

UR - http://www.scopus.com/inward/record.url?scp=0019929035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019929035&partnerID=8YFLogxK

U2 - 10.1002/jso.2930210111

DO - 10.1002/jso.2930210111

M3 - Article

C2 - 7109635

AN - SCOPUS:0019929035

VL - 21

SP - 42

EP - 44

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -